40 ml of semaglutide Flex-Dose 1 Injectable 2.5 mg/mL Obesema(semaglutide) 0.5mg Injection (1 Multi-dose

This government-funded health plan hasn't previously covered GLP-1s for weight loss

Patients may have personalized dosages to help mitigate side effects or for other medical reasons

doi: 10.3389/fphar.2025.1737199 Received 01 November 2025 Revised 21 December 2025 Accepted 29 December 2025 Published 15 January 2026 Volume 16 - 2025 Edited by Dawei Chen, University of Kiel, Germany Reviewed by Eveljn Scarian, University of Pavia, Italy Hong Cheng, Yangzhou University, China Updates Copyright 2026 Knudsen, Tadje, Coggins and Venketaraman

View Full Clinical Case Study #2 The patient manages obesity, chronic knee pain, and elevated glucose of 106 mg/dL